DimitriosMiserlisMD
Vascular Surgery • Austin, TXVascular and Endovascular Surgery UT Austin Dell Biomedical Technologies and Therapeutics Research and Development
Dr. Miserlis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 Red River St
Austin, TX 78701Phone+1 512-324-7507- Is this information wrong?
Summary
- Vascular and Endovascular Surgery
UT Austin Dell
Biomedical Technologies and Therapeutics Research and Development
Faculty Electrical and Computer Science, UTSA
Biomedical Engineering
Joint Graduate Program UTSA-UTHSCSA 2018-2022
Biomedical Artificial Intelligence and Mechatronics Applications Research Laboratory UTHSCSA 2018 -2022
Education & Training
Nebraska Medicine - Nebraska Medical CenterVascular and Endovascular Surgery, 2016 - 2018- University of Nebraska Medical Center College of MedicineResidency, Surgery, 2011 - 2016
- Nebraska Medicine - Nebraska Medical CenterPost-Doctoral Fellowship, Vascular Surgery Translational Research and Biomedical Technologies, 2009 - 2011
University of Crete School of Health SciencesClass of 2001
Certifications & Licensure
NE State Medical License 2016 - 2024
TX State Medical License 2018 - 2024- American Board of Surgery Surgery
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Scientific Research Honor Society Sigma Xi, 2021
- President's Translational and Entrepreneurial Research Fund Award University of Texas - Health Science Center at San Antonio, 2020
- Innvation Award - Innovations - Medical Device Development University of Nebraska - Unemed, 2016
Publications & Presentations
PubMed
- Oxidative damage in the gastrocnemius predicts long-term survival in patients with peripheral artery disease.Panagiotis Koutakis, Hernan Hernandez, Jonathan R Thompson, Evlampia Papoutsi, Gleb Haynatzki, Julian K Kim, George P Casale, Dimitrios Miserlis, Constance J Mietus, I...> ;Npj Aging. 2024 Apr 5
- Mitochondrial fatty acid beta-oxidation: a possible therapeutic target for skeletal muscle lipotoxicity in peripheral artery disease myopathy.Cassandra E Bradley, Emma Fletcher, Trevor Wilkinson, Andrew Ring, Lucas Ferrer, Pal Pacher, Panagiotis Koutakis, Dimitrios Miserlis> ;EXCLI Journal. 2024 Jan 1
- Diet-induced obesity augments ischemic myopathy and functional decline in a murine model of peripheral artery disease.Emma Fletcher, Dimitrios Miserlis, Kristina Sorokolet, Dylan Wilburn, Cassandra Bradley, Evlampia Papoutsi, Trevor Wilkinson, Andrew Ring, Lucas Ferrer, Gleb Haynatzki...> ;Translational Research. 2023 Oct 1
- Join now to see all
Other
- Fuzzy Logic Navigation System for Autonomous Endovascular OperationsDimitrios Miserlis; Amir Jafari; Teja Guda; Miltiadis Alamaniotis
https://ieeexplore.ieee.org/document/9288013
IEEE - 12/16/2020
Hospital Affiliations
Dell Seton Medical Center at The University of TexasAustin, Texas
External Links
- Unemedhttps://www.unemed.com/news/unemed-signs-deal-device-air-leaks-chest-tubes
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
